An Observational Study Conducted in China to Evaluate the Efficacy and Safety of Darolutamide in Combination With Androgen Deprivation Therapy (ADT) for Men With Non-metastatic Prostate Cancer That Progressed Following Prior Bicalutamide + ADT Treatment
Clinical trial NCT07538843 · RECRUITING
Trial details
- NCT number
- NCT07538843
- Sponsor
- Bayer
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-07-31
- Primary completion
- 2029-11-01
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.